For the quarter ending 2025-12-31, CTXR has $140,391,730 in assets. $46,923,760 in debts. $7,721,393 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 7,721,393 | 4,252,290 | 6,089,126 | |
| Accounts receivable, net of allowances | 4,049,111 | - | - | |
| Inventory | 22,639,342 | 22,286,693 | 17,208,967 | |
| Prepaid expenses | 3,535,287 | 1,395,490 | 1,313,176 | |
| Total current assets | 37,945,133 | 27,934,473 | 24,611,269 | |
| Operating lease right-of-use asset, net | 835,177 | 818,694 | 880,732 | |
| Deposits | 38,062 | 38,062 | 38,062 | |
| In-process research and development, net of accumulated amortization | 92,226,562 | 92,800,000 | 92,800,000 | |
| Goodwill | 9,346,796 | 9,346,796 | 9,346,796 | |
| Total other assets | 101,611,420 | 102,184,858 | 102,184,858 | |
| Total assets | 140,391,730 | 130,938,025 | 127,676,859 | |
| Accounts payable | 11,021,412 | 13,693,692 | 10,094,042 | |
| License payable | 18,250,000 | 22,650,000 | 28,400,000 | |
| Accrued expenses | 4,693,307 | 4,190,253 | 8,523,675 | |
| Accrued compensation | 3,094,395 | 3,292,447 | 3,710,041 | |
| Note payable | 1,000,000 | 1,000,000 | 1,000,000 | |
| Operating lease liability | 148,006 | 88,348 | 114,694 | |
| Total current liabilities | 38,207,120 | 44,914,740 | 51,842,452 | |
| Deferred tax liability | 8,035,000 | 7,770,760 | 7,506,520 | |
| Operating lease liability noncurrent | 681,640 | 724,925 | 766,957 | |
| Total liabilities | 46,923,760 | 53,410,425 | 60,115,929 | |
| Common stock - 0.001 par value 250,000,000 shares authorized 22,376,427 and 18,067,744 shares issued and outstanding at december 31, 2025 and september 30, 2025, respectively | 22,376 | 18,068 | 14,475 | |
| Additional paid-in capital | 326,960,700 | 306,336,239 | 295,888,916 | |
| Accumulated deficit | -247,024,914 | -238,804,129 | -230,844,841 | |
| Total citius pharmaceuticals, inc. stockholders equity | 79,958,162 | 67,550,178 | 65,058,550 | |
| Non-controlling interest | 13,509,808 | 9,977,422 | 2,502,380 | |
| Total equity | 93,467,970 | 77,527,600 | 67,560,930 | |
| Total liabilities and equity | 140,391,730 | 130,938,025 | 127,676,859 | |
Citius Pharmaceuticals, Inc. (CTXR)
Citius Pharmaceuticals, Inc. (CTXR)